Skip to content
OpenCongress is in beta. We'd love your feedback!Share feedback

HR6977-119

To provide for the periodic issuance of up-to-date clinical guidance on addressing the health effects of per- and polyfluoroalkyl substances (PFAS), and for other purposes.

Introduced in HouseΒ· Jan 8, 2026
Loading text…
Full Text Β· HR6977-119 β€” OpenCongress